Safety and Immunogenicity of SUM-101 Malaria Vaccine in Children and Infants Living in Burkina Faso

PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 1, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

August 31, 2026

Conditions

Malaria,Falciparum

Interventions

BIOLOGICAL

SUM-101

Three immunizations every 4 weeks for 3 months (total 3 immunizations)

Trial Locations (1)

RECRUITING

Groupe de Recherche Action en Santé (GRAS), Ouagadougou

All Listed Sponsors

collaborator

Groupe de Recherche Action en Sante

OTHER

collaborator

Luxembourg Institute of Health

OTHER_GOV

lead

European Vaccine Initiative

OTHER

NCT06618885 - Safety and Immunogenicity of SUM-101 Malaria Vaccine in Children and Infants Living in Burkina Faso | Biotech Hunter | Biotech Hunter